A phase II study of lenvatinib plus pembrolizumab in patients with recurrent/metastatic salivary gland cancers.

Authors: Alan Loh Ho, Eric Jeffrey Sherman, Anuja Kriplani, James Vincent Fetten, Loren Scott Michel, Michael Hwang, Shrujal S. Baxi, Winston Wong, Lara Dunn, Irina Ostrovnaya, David G. Pfister

Published: 2025-05-28

DOI: 10.1200/jco.2025.43.16_suppl.6103

Source: Full article


Abstract

6103